Particle Data Platform

NPR News: 05-14-2026 6PM EDT

5/14/20265 min

NPR News: 05-14-2026 6PM EDT

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy

Transcript preview

First 90 seconds
  1. Jeanine Herbst· Host0:00

    Live from NPR News in Washington, I'm Jeanine Herbst. The Supreme Court today has preserved access to the widely used abortion pill mifepristone, allowing it to be available by mail without an in-person appointment. The case stems from a suit Louisiana filed to roll back the FDA's rules on how the drug can be prescribed. A ruling by a three-judge panel of the Fifth U.S. Circuit Court of Appeals on May 1st threatened access to the pill through telemedicine visits and mail delivery. But tonight, the High Court granted emergency requests by two drug makers of the pill to block the lower court ruling for now while a lawsuit plays out. Medication abortions account for nearly two-thirds of all abortions in the U.S. as of twenty twenty-three, the last year for which statistics are available. President Trump and Chinese leader Xi Jinping met in Beijing today, discussing the war in Iran, global trade, and energy security. But as NPR's Tamara Keith reports, it doesn't appear that the talks between the two yielded any significant progress.

  2. Tamara Keith1:04

    On Thursday, Trump and Xi held a bilateral meeting that, for a time, included CEOs from top U.S. corporations. Then in the evening at a formal banquet, the two leaders toasted each other and the relationship between their nations. Trump made clear he wants this visit to be the start of a longer dialogue.

  3. Donald Trump· Soundbite1:23

    Tonight, it is my honor to extend an invitation to you and Madam Peng to visit us

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.